Optimizing treatment administration strategies using negative mNGS results in corticosteroid-sensitive diffuse parenchymal lung diseases.
Jing C, Ding Y, Zhou J, Zhang Q, Wang M, Ou Q, Liu J, Xv T, Feng C, Yuan D, Wu T, Weng T, Xv X, Dai S, Qian Q, Sun W.
Jing C, et al. Among authors: xv x.
iScience. 2024 Jun 7;27(7):110218. doi: 10.1016/j.isci.2024.110218. eCollection 2024 Jul 19.
iScience. 2024.
PMID: 38993672
Free PMC article.